Stay updated on Oncolytics Biotech Press Releases

Sign up to get notified when there's something new on the Oncolytics Biotech Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Oncolytics Biotech Press Releases page

  1. Check
    3 days ago
    Change Detected
    Summary
    Stock information on the Investor Overview page has been updated to reflect a price of $0.84 and a 5.11% change as of August 18, 2026. A new press release about FDA alignment with the registrational path was added, and an older patent-related press release was removed.
    Difference
    3%
    Check dated 2026-08-22T23:29:28.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Stock price updated from $0.80, $0.001 change, and 0.12% to $0.83, $0.034 change, and 4.25%, respectively. These figures represent the latest market activity displayed on the Investor Overview page.
    Difference
    0.9%
    Check dated 2026-08-16T01:29:03.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The stock quote values on the Investor Overview were updated: the price moved from $0.75 to $0.80, the intraday change from 0 to 0.001, and the percent change from 0.00% to 0.12%. These updates reflect current financial data presented to investors.
    Difference
    0.8%
    Check dated 2026-08-08T23:04:24.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The investor stock quote block now displays a current price of $0.75 with a daily percentage change of 0.00%. This replaces the prior quote of $0.81 and a -4.25% daily change.
    Difference
    0.8%
    Check dated 2026-08-01T17:50:28.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The investor page now displays the latest NASD:ONCY stock figures and adds a Fast Track designation press release; an older stock quote and a governance-related appointment announcement were removed.
    Difference
    3%
    Check dated 2026-07-25T13:25:23.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The stock quote on the Investor Overview page is updated to $0.85 with a -0.03 change and -3.40%, replacing the previous $0.89, -0.033, -3.59% figures. A new press release headline about FDA regulatory milestone and strong clinical progress in a randomized RAS-mutant MSS colorectal cancer trial was added, and the June 1, 2026 press release listing was removed.
    Difference
    3%
    Check dated 2026-07-18T09:20:27.000Z thumbnail image

Stay in the know with updates to Oncolytics Biotech Press Releases

Enter your email address, and we'll notify you when there's something new on the Oncolytics Biotech Press Releases page.